Interestingly, potential targets of miR196a2 include genes with relevance in CLL, such as CDKN1B or HMOX1. Therefore, alterations in the sequence of miR196a2 which may affect miRNA function, could contribute to CLL risk due to the deregulation of its targets. This evidence concerns the gene CDKN1B and B-cell chronic lymphocytic leukemia.